Anthony M. Manning
Momenta Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
NF-κB Signaling Pathways, Cytokine Signaling Pathways and Interactions, Monoclonal and Polyclonal Antibodies Research, Immune Response and Inflammation, Glycosylation and Glycoproteins Research
Most-Cited Works
- → SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase(2001)2,554 cited
- → IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation(1997)2,040 cited
- → Identification of the receptor component of the IκBα–ubiquitin ligase(1998)655 cited
- → Targeting JNK for therapeutic benefit: from junk to gold?(2003)582 cited
- → Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53‐independent pathway: Implications for the possible role of dietary fibre in the prevention of large‐bowel cancer(1993)535 cited
- → Multiple signals converging on NF-κB(1999)475 cited
- → NF-κB as a primary regulator of the stress response(1999)409 cited
- → IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex(1999)326 cited
- → Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity(2015)224 cited
- → Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells(1998)184 cited